Michael Mollerus

Davis Polk advised the joint book-running managers on an SEC-registered offering by LYB International Finance II B.V., a wholly owned subsidiary of LyondellBasell Industries N.V., of €750…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of €1 billion aggregate principal amount of its floating…

Davis Polk advised the representatives of the several underwriters, on an SEC-registered offering by General Motors Company of $2.0 billion in aggregate principal amount of senior notes,…

Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of $900 million principal amount of its floating-rate notes due 2017,…

Davis Polk advised underwriters in connection with the offering of C$750 million aggregate principal amount of 1.95% bonds due January 27, 2023, issued by the Province of Ontario. The net…

Davis Polk is advising Lightyear Capital LLC and Clarion Partners Holdings LLC on the sale of Clarion Partners to Legg Mason, Inc. The transaction is subject to customary regulatory and…

Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc. where Acorda will make a public tender offer in Finland and the…

Davis Polk is advising the dealer managers in connection with cash tender offers by ERP Operating Limited Partnership, an operating partnership subsidiary of Equity Residential (the …

Davis Polk advised the underwriters in connection with the SEC-registered offering of 4,166,167 shares of common stock of Cempra, Inc. The net proceeds to Cempra were approximately $93.7…

Davis Polk is advising Charles River Laboratories International, Inc. on its acquisition of WIL Research for approximately $585 million. The transaction, which is expected to close early in…